Nathalie Nicolaiew Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2023	The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer.
5/2015	Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.
7/2013	Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.
3/2011	Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance.
11/2010	Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy.
11/2010	The effect of prostate-specific antigen screening during the last decade: development of clinicopathological variables independently of the biopsy core number.
1/2009	Association between estrogen and androgen receptor genes and prostate cancer risk.
10/2007	Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.
8/2007	Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathalie Nicolaiew Research Topics

Disease

9	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 08/2007
4	Neoplasms (Cancer) 05/2015 - 02/2010
2	Carcinoma (Carcinomatosis) 05/2015 - 08/2007
1	Prostatic Intraepithelial Neoplasia 03/2009
1	Carcinogenesis 01/2009

Drug/Important Bio-Agent (IBA)

3	Prostate-Specific Antigen (Semenogelase)IBA 05/2015 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 05/2015 - 11/2010
2	Androgen Receptors (Androgen Receptor)IBA 07/2013 - 01/2009
2	Estrogens (Estrogen)FDA Link 01/2009 - 08/2007
1	Neuropilin-1IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	Kazal Pancreatic Trypsin InhibitorIBA 05/2015
1	AndrogensIBA 07/2013
1	LigandsIBA 07/2013
1	AntigensIBA 03/2011
1	taxaneIBA 11/2010
1	Docetaxel (Taxotere)FDA Link 11/2010
1	TubulinIBA 11/2010
1	SteroidsIBA 01/2009
1	Hormones (Hormone)IBA 01/2009
1	Finasteride (Propecia)FDA LinkGeneric 10/2007
1	EnzymesIBA 10/2007
1	Aromatase (CYP19)IBA 08/2007
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 08/2007

Therapy/Procedure

2	Castration 07/2013 - 11/2010
2	Therapeutics 07/2013 - 11/2010
1	Aftercare (After-Treatment) 11/2010
1	Drug Therapy (Chemotherapy) 11/2010
1	Prostatectomy (Retropubic Prostatectomy) 11/2010
1	Chemoprevention 10/2007